Jessica Lo, Eunice Yuen Ting Lau, Rachel Hiu Ha Ching, Bowie Yik Ling Cheng, Mark Kin Fai Ma, Irene Oi Lin Ng, Terence Kin Wah Lee – 21 April 2015 – Sorafenib is a new standard treatment for patients with advanced hepatocellular carcinoma (HCC). However, the survival benefit of this treatment is modest, partly owing to drug resistance. Recent evidence has demonstrated the existence of tumor‐initiating cells (T‐ICs) as the culprit for treatment resistance.

Oliviero Riggio, Silvia Nardelli, Stefania Gioia, Cristina Lucidi, Manuela Merli – 21 April 2015 – Watch a video presentation of this article

Oliviero Riggio, Silvia Nardelli, Stefania Gioia, Cristina Lucidi, Manuela Merli – 21 April 2015 – Watch a video presentation of this article

Radha K. Dhiman – 21 April 2015 – Watch a video presentation of this article

Jean‐François Dufour – 20 April 2015

Jean‐François Dufour – 20 April 2015

Jun Zhao, Matthew W. Lawless – 18 April 2015

Adriaan J. van der Meer – 18 April 2015

Edouard Bardou‐Jacquet, Marie de Tayrac, Jean Mosser, Yves Deugnier – 18 April 2015

Daniel J. Antoine, Venkata S. Sabbisetti, Ben Francis, Andrea L. Jorgensen, Darren G.N. Craig, Kenneth J. Simpson, Joseph V. Bonventre, B. Kevin Park, James W. Dear – 18 April 2015 – Acute kidney injury in the context of acetaminophen (APAP; paracetamol)‐induced liver injury is an important predictor of the requirement for urgent liver transplantation (LT) to avoid death. However, the prognostic biomarker used to report kidney dysfunction (serum creatinine concentration) has suboptimal sensitivity and specificity.